Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
366-03-009 ISMRM Abstract

Spatiotemporal Delta Radiomics for Predicting Axillary Lymph Node Metastasis in Breast Cancer

Accepted
Hui Yang1,2,3, Shuluan Chen4, Xuetong Tao1,3, Xuanle Li1,3,5, Kexin Chen1,3,6, Ya Ren4, Meng Wang4, Lin Li4, Jie Wen4, wei cui7, Xin Liu1,3, Dong Liang1,3, Hairong Zheng1,3, Zhanli Hu1,3, Zhou Liu 4, Na Zhang1,3
1Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
2College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, nanjing, China
3State Key Laboratory of Biomedical Imaging Science and System, Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, China
4Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
5Faculty of Data Science, City University of Macau, Macau, China
6Southern University of Science and Technology, Shenzhen, China
7GE Healthcare, Beijing, China
Presenting Author: Zhou Liu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660. PMID: 33538338 [doi] [pmid]
2. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. doi:10.3322/caac.21820. PMID: 38151114 [doi] [pmid]
3. Kootstra JJ, Dijkstra PU, Rietman H, et al. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat. 2013;139(1):125–134. doi:10.1007/s10549-013-2510-3. PMID: 23595821 [doi] [pmid]
4. Kootstra JJ, Hoekstra-Weebers JE, Rietman H, et al. Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol. 2008;15(9):2533–2541. doi:10.1245/s10434-008-0058-4. PMID: 18636289 [doi] [pmid]
5. Han L, Zhu Y, Liu Z, et al. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019;29(7):3820–3829. doi:10.1007/s00330-019-06137-7. PMID: 30796430 [doi] [pmid]
6. Wang D, Hu Y, Zhan C, Zhang Q, Wu Y, Ai T. A nomogram based on radiomics signature and deep-learning signature for preoperative prediction of axillary lymph node metastasis in breast cancer. Front Oncol. 2022;12:940655. doi:10.3389/fonc.2022.940655. PMID: 36387512 [doi] [pmid]

Cite this abstract